CTEP Branches and Offices
Last Updated: 01/10/25
Agent Management
- Policy and Guidelines for Investigational Agent Distribution (PDF) (01/22)
- Policy and Guidelines for Investigational Agent Ordering (PDF) (10/01/21)
- Policy and Guidelines for Accountability and Storage of Investigational Agents (PDF) (02/22)
- Policy and Guidelines for Investigational Agent Transfers (PDF) (06/01/14)
- Policy and Guidelines for Investigational Agent Returns (PDF) (06/01/14)
- Policy and Guidelines for Investigational Agent Local Destruction (PDF) (09/01/16)
- Guideline for Shipping Oral IND Agents to Clinical Trial Subjects (PDF) (01-JAN-2022)
- Links to Commercial Drug Shortage Resources
- http://www.fda.gov/medwatch — to enroll in Medwatch and receive e-mails when shortages are identified by FDA
- https://www.fda.gov/drugs/drug-safety-and-availability/drug-shortages — FDA Web site for drug shortages. Provides most current information from FDA
- https://www.ashp.org/drug-shortages/current-shortages — ASHP web site for drug shortages. Information regarding shortages from American Society of Health Systems Pharmacists.
- http://www.cdc.gov/vaccines/vac-gen/shortages/default.htm — CDC website for Vaccine shortages
About the Branch Chief (Acting)
Matthew J. Boron, RPh joined the Cancer Therapy Evaluation Program (CTEP) in 2000 as a Clinical Research Pharmacist in
the Drug Management and Authorization Section (DMAS) of the Pharmaceutical Management Branch (PMB), where he was
responsible for a portfolio of biologic agents under CTEP Investigational New Drug applications (INDs). In 2002, he
transitioned to management of the Treatment Referral Center (TRC). More…